REVIEW
|
doi:10.20944/preprints202304.0038.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
lung cancer; SARS-CoV-2 vaccine; immunogenicity
Online: 4 April 2023 (04:58:31 CEST)